Filing Details
TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:TMCI
TREACE MEDICAL CONCEPTS, INC. (TMCI) Files Quarterly Report for Q0
TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) filed its quarterly report (Form 10-Q) on August 07, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $4.76 with a market capitalization of $183.6 million as of the filing date.
- The quarterly report contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing, though specific revenue figures and financial results are not disclosed in this summary.
Market Context
TREACE MEDICAL CONCEPTS, INC.'s stock currently trades at $4.76 with a market capitalization of $183.6M.
The 10-Q provides TREACE MEDICAL CONCEPTS, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for TREACE MEDICAL CONCEPTS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TMCI Stock Page
Frequently Asked Questions
Where can I read TMCI's SEC filings?
Browse all filings on our TMCI SEC filings page.
What types of SEC filings does TREACE MEDICAL CONCEPTS, INC. file?
Public companies like TREACE MEDICAL CONCEPTS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
